Infant brain tumor trials: Beyond feasibility
Neuro Oncol
.
2022 Jul 1;24(7):1191-1192.
doi: 10.1093/neuonc/noac065.
Authors
Eric Bouffet
1
,
Lucie Lafay-Cousin
2
Affiliations
1
Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
2
Section of Pediatric Hematology/Oncology and Bone Marrow Transplantation, Alberta Children's Hospital, Calgary, Alberta, Canada.
PMID:
35287175
PMCID:
PMC9248399
DOI:
10.1093/neuonc/noac065
No abstract available
Publication types
Editorial
Comment
MeSH terms
Brain Neoplasms* / therapy
Child
Child, Preschool
Feasibility Studies
Humans
Infant
Isotretinoin*
Vorinostat
Substances
Vorinostat
Isotretinoin